Infection is the second leading cause of death in patients with cancer. Loss of efficacy in
antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing …

Adoptive immunotherapy using B-cell–targeted chimeric antigen receptor (CAR)-modified T
cells to treat hematologic malignancies is transforming cancer care for patients with …

Febrile neutropenia remains an important complication of treatment with cytotoxic
chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this …

Paediatric patients with cancer and those undergoing haematopoietic cell transplantation
are at high risk of bacterial infections. The 8th European Conference on Infections in …

Background Myeloma causes profound immunodeficiency and recurrent, serious infections.
Around 5500 new cases of myeloma are diagnosed per year in the UK, and a quarter of …

Hematologic and oncologic patients with chemo-or immunotherapy-related
immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii …

Acute leukemias are a group of aggressive malignant diseases associated with a high
degree of morbidity and mortality. An important cause of both the latter is infectious …

Background Early antibiotic discontinuation has been advocated in haematology patients
with fever of unknown origin during chemotherapy-induced neutropenia, but its safety is …

Background Pseudomonas aeruginosa (PA) bloodstream infection (BSI) is a common
complication in patients with acute leukemia (AL), and the prevalence of antibiotic-resistant …

Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems
worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse …